WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, October 15, 2003, 23(28):9403-9408

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (72)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fridmacher, V.
Right arrow Articles by Mémet, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fridmacher, V.
Right arrow Articles by Mémet, S.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH

 Previous Article  |  Next Article 

BRIEF COMMUNICATION
Forebrain-Specific Neuronal Inhibition of Nuclear Factor-{kappa}B Activity Leads to Loss of Neuroprotection

Valérie Fridmacher,1 * Barbara Kaltschmidt,3 * Bertrand Goudeau,1 Delphine Ndiaye,1 Francesco Mattia Rossi,2 Julia Pfeiffer,3 Christian Kaltschmidt,3 Alain Israël,1 and Sylvie Mémet1

1Unité de Biologie Moléculaire de l'Expression Génique, Unité de Recherche Associée Centre National de la Recherche Scientifique 2582, 2Unité Récepteurs et Cognition, Centre National de la Recherche Scientifique Unité de Recherche Associée 2182, Institut Pasteur, 75724 Paris Cedex 15, France, and 3University of Witten/Herdecke Institut für Neurobiochemie, 58448 Witten, Germany

The transcription factor Rel/nuclear factor (NF)-{kappa}B is known for its fundamental role in regulating immune and inflammatory responses. In the brain, constitutive NF-{kappa}B activity has been detected exclusively in neurons, and a large diversity of stimuli have been reported to induce NF-{kappa}B activity. Yet the function of this transcription factor in the nervous system remains unclear, and its role in neuroprotection or neurodegeneration is open to debate. Recently it was suggested that {kappa}B-driven gene expression in neurons is controlled by Sp1-like factors. To clarify such controversy, we have characterized here a novel mouse model in which the entire NF-{kappa}B-dependent transcriptional response is abolished in the forebrain. Calcium-calmodulin-dependent kinase II {alpha} promoter-driven tetracycline transactivator was used for regulated expression of a transdominant negative mutant of inhibitor {kappa}B{alpha} (super-repressor) together with a green fluorescent protein tracer. Inhibition of expression of a {kappa}B-dependent lacZ transgene was shown in triple transgenic mice, which correlated with the loss of {kappa}B-specific DNA binding. In transgenic organotypic hippocampal slice cultures, expression of the super-repressor led to strong cell death after neurotoxic insults. These data demonstrate for the first time that neuron-restricted ablation of NF-{kappa}B-driven gene expression increases neurodegeneration. This might lead to the path for new treatments of neurodegenerative diseases.

Key words: transcription factor NF-{kappa}B; brain; tetracycline; neuroprotection; organotypic hippocampal slice cultures; kainate; ferrous sulfate; transgenic mice


Received Feb 6, 2003; revised August 20, 2003; accepted August 28, 2003.




This article has been cited by other articles:


Home page
Cold Spring Harb. Perspect. Biol.Home page
B. Kaltschmidt and C. Kaltschmidt
NF-{kappa}B in the Nervous System
Cold Spring Harb Perspect Biol, September 1, 2009; 1(3): a001271 - a001271.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. H.A. Nijboer, C. J. Heijnen, F. Groenendaal, M. J. May, F. van Bel, and A. Kavelaars
Strong Neuroprotection by Inhibition of NF-{kappa}B After Neonatal Hypoxia-Ischemia Involves Apoptotic Mechanisms but Is Independent of Cytokines
Stroke, July 1, 2008; 39(7): 2129 - 2137.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. J. Edenberg, X. Xuei, L. F. Wetherill, L. Bierut, K. Bucholz, D. M. Dick, V. Hesselbrock, S. Kuperman, B. Porjesz, M. A. Schuckit, et al.
Association of NFKB1, which encodes a subunit of the transcription factor NF-{kappa}B, with alcohol dependence
Hum. Mol. Genet., April 1, 2008; 17(7): 963 - 970.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Taoufik, S. Valable, G. J. Muller, M. L. Roberts, D. Divoux, A. Tinel, A. Voulgari-Kokota, V. Tseveleki, F. Altruda, H. Lassmann, et al.
FLIPL Protects Neurons against In Vivo Ischemia and In Vitro Glucose Deprivation-Induced Cell Death
J. Neurosci., June 20, 2007; 27(25): 6633 - 6646.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Inta, S. Paxian, I. Maegele, W. Zhang, M. Pizzi, P. Spano, I. Sarnico, S. Muhammad, O. Herrmann, D. Inta, et al.
Bim and Noxa Are Candidates to Mediate the Deleterious Effect of the NF-{kappa}B Subunit RelA in Cerebral Ischemia
J. Neurosci., December 13, 2006; 26(50): 12896 - 12903.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. O'Mahony, J. Raber, M. Montano, E. Foehr, V. Han, S.-m. Lu, H. Kwon, A. LeFevour, S. Chakraborty-Sett, and W. C. Greene
NF-{kappa}B/Rel Regulates Inhibitory and Excitatory Neuronal Function and Synaptic Plasticity.
Mol. Cell. Biol., October 1, 2006; 26(19): 7283 - 7298.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Navarrete, R. Sancho, F. J. Caballero, F. Pollastro, B. L. Fiebich, O. Sterner, G. Appendino, and E. Munoz
Basiliolides, a Class of Tetracyclic C19 Dilactones from Thapsia garganica, Release Ca2+ from the Endoplasmic Reticulum and Regulate the Activity of the Transcription Factors Nuclear Factor of Activated T Cells, Nuclear Factor-{kappa}B, and Activator Protein 1 in T Lymphocytes
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 422 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Qiu, F. Norflus, B. Singh, M. K. Swindell, R. Buzescu, M. Bejarano, R. Chopra, B. Zucker, C. L. Benn, D. P. DiRocco, et al.
Sp1 Is Up-regulated in Cellular and Transgenic Models of Huntington Disease, and Its Reduction Is Neuroprotective
J. Biol. Chem., June 16, 2006; 281(24): 16672 - 16680.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Kaltschmidt, D. Ndiaye, M. Korte, S. Pothion, L. Arbibe, M. Prullage, J. Pfeiffer, A. Lindecke, V. Staiger, A. Israel, et al.
NF-{kappa}B Regulates Spatial Memory Formation and Synaptic Plasticity through Protein Kinase A/CREB Signaling
Mol. Cell. Biol., April 15, 2006; 26(8): 2936 - 2946.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Tao, D. Yan, Q. Yang, R. Zeng, and Y. Wang
Low K+ Promotes NF-{kappa}B/DNA Binding in Neuronal Apoptosis Induced by K+ Loss
Mol. Cell. Biol., February 1, 2006; 26(3): 1038 - 1050.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Chen, Y. Zhou, S. Mueller-Steiner, L.-F. Chen, H. Kwon, S. Yi, L. Mucke, and L. Gan
SIRT1 Protects against Microglia-dependent Amyloid-{beta} Toxicity through Inhibiting NF-{kappa}B Signaling
J. Biol. Chem., December 2, 2005; 280(48): 40364 - 40374.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Bourteele, K. Oesterle, S. Pleschka, G. Unterstab, C. Ehrhardt, T. Wolff, S. Ludwig, and O. Planz
Constitutive Activation of the Transcription Factor NF-{kappa}B Results in Impaired Borna Disease Virus Replication
J. Virol., May 15, 2005; 79(10): 6043 - 6051.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
H. Gutierrez, V. A. Hale, X. Dolcet, and A. Davies
NF-{kappa}B signalling regulates the growth of neural processes in the developing PNS and CNS
Development, April 1, 2005; 132(7): 1713 - 1726.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. E. Jung, M. B. Gatch, and J. W. Simpkins
Estrogen Neuroprotection Against the Neurotoxic Effects of Ethanol Withdrawal: Potential Mechanisms
Experimental Biology and Medicine, January 1, 2005; 230(1): 8 - 22.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Potrovita, W. Zhang, L. Burkly, K. Hahm, J. Lincecum, M. Z. Wang, M. H. Maurer, M. Rossner, A. Schneider, and M. Schwaninger
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis-Induced Neurodegeneration
J. Neurosci., September 22, 2004; 24(38): 8237 - 8244.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Marchetti, M. Klein, K. Schlett, K. Pfizenmaier, and U. L. M. Eisel
Tumor Necrosis Factor (TNF)-mediated Neuroprotection against Glutamate-induced Excitotoxicity Is Enhanced by N-Methyl-D-aspartate Receptor Activation: ESSENTIAL ROLE OF A TNF RECEPTOR 2-MEDIATED PHOSPHATIDYLINOSITOL 3-KINASE-DEPENDENT NF-{kappa}B PATHWAY
J. Biol. Chem., July 30, 2004; 279(31): 32869 - 32881.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-